melanotes The Johns Hopkins (@jhumelanotes) • Facebook RIGHT BACK RIGHT BACK RIGHT

An overview on therapeutics attenuating amyloid level in Alzheimers disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels

Dihexa: The Cognitive Enhancer That Could Reshape Brain Health How this powerful peptide targets synapse formation, neuroprotection, and memory restoration Introduction Neurodegenerative diseases, cognitive decline, and even everyday brain fog have one thing in common: disrupted communication between neurons

Methods: We conducted a double-blinded, dose-escalation, phase I study to determine the optimal dosage of chlorpromazine and promethazine that is safe and induces a torpor-like status in acute ischemic stroke (AIS) patients

Week 1-2: Adjustment phase The first two weeks primarily involve physiological adjustment rather than visible results

Most patients do not experience anything but gradual improvements